Work Here?
Work Here?
Work Here?
Industries
Biotechnology
Healthcare
Company Size
10,001+
Company Stage
IPO
Total Funding
$3.2M
Headquarters
Fridley, Minnesota
Founded
1949
Medtronic provides medical technology, services, and solutions to improve patient care. The company develops a variety of medical devices, including pacemakers, insulin pumps, surgical tools, and neurostimulation devices, which help diagnose, prevent, and treat chronic diseases. These products are used by hospitals and healthcare professionals around the world. Medtronic stands out from competitors by not only focusing on product development but also offering comprehensive services such as training for healthcare providers and patient management programs. The goal of Medtronic is to enhance patient outcomes and lower healthcare costs through its advanced medical solutions.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$3.2M
Above
Industry Average
Funded Over
3 Rounds
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Employee Assistance Program
Wellness Program
Medtronic acquires certain nano surface technology from Nanovis.
GALWAY, Ireland, Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's third quarter of fiscal year 2025, which ended on Friday, January 24, 2025. Medtronic will host a video webcast at 7:00 a.m
GALWAY, Ireland, Jan. 21, 2025 /PRNewswire/ - Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Thierry Piéton has been appointed Chief Financial Officer for the company, effective March 3, 2025.
Medtronic's heart rhythm management portfolio, including its insertable cardiac monitors (ICMs) and pulsed field ablation (PFA) systems, have had a significant footprint at AF Symposium 2025, a three-day conference in Boston focused on advanced atrial fibrillation (AFib) technologies.
Recall that Medtronic acquired the renal denervation technology from Mountain View, California-based Ardian back in 2010 for $800 million plus milestone payments.
Find jobs on Simplify and start your career today
Industries
Biotechnology
Healthcare
Company Size
10,001+
Company Stage
IPO
Total Funding
$3.2M
Headquarters
Fridley, Minnesota
Founded
1949
Find jobs on Simplify and start your career today